165 related articles for article (PubMed ID: 32521610)
21. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
22. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
Zhang H; Wang Z
Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
[TBL] [Abstract][Full Text] [Related]
23. Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release.
Goddeeris C; Goderis B; Van den Mooter G
Eur J Pharm Sci; 2010 May; 40(2):110-7. PubMed ID: 20298780
[TBL] [Abstract][Full Text] [Related]
24. The Monoglyceride Content Affects the Self-Assembly Behavior, Rheological Properties, Syringeability, and Mucoadhesion of In Situ-Gelling Liquid Crystalline Phase.
Nunes KM; Teixeira CC; Kaminski RC; Sarmento VH; Couto RO; Pulcinelli SH; Freitas O
J Pharm Sci; 2016 Aug; 105(8):2355-64. PubMed ID: 27339408
[TBL] [Abstract][Full Text] [Related]
25. Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures.
Johnsson M; Lam Y; Barauskas J; Tiberg F
Langmuir; 2005 May; 21(11):5159-65. PubMed ID: 15896065
[TBL] [Abstract][Full Text] [Related]
26. Development and In Vitro Evaluation of Lyotropic Liquid Crystals for the Controlled Release of Dexamethasone.
Oyafuso MH; Carvalho FC; Takeshita TM; De Souza ALR; Araújo DR; Merino V; Gremião MPD; Chorilli M
Polymers (Basel); 2017 Aug; 9(8):. PubMed ID: 30971006
[TBL] [Abstract][Full Text] [Related]
27. Formulation of lyotropic liquid crystal containing mulberry stem extract: influences of formulation ingredients on the formation and the nanostructure.
Yhirayha C; Soontaranon S; Wittaya-Areekul S; Pitaksuteepong T
Int J Cosmet Sci; 2014 Jun; 36(3):213-20. PubMed ID: 24471700
[TBL] [Abstract][Full Text] [Related]
28. Automation of liquid crystal phase analysis for SAXS, including the rapid production of novel phase diagrams for SDS-water-PIL systems.
Paporakis S; Binns J; Yalcin D; Drummond CJ; Greaves TL; Martin AV
J Chem Phys; 2023 Jan; 158(1):014902. PubMed ID: 36610972
[TBL] [Abstract][Full Text] [Related]
29. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase.
Mishraki-Berkowitz T; Aserin A; Garti N
J Colloid Interface Sci; 2017 Jan; 486():184-193. PubMed ID: 27701016
[TBL] [Abstract][Full Text] [Related]
30. Rich liquid crystal phase behavior of novel alkyl-tri(ethylene glycol)-glucoside carbohydrate surfactants.
Moore JE; McCoy TM; Marlow JB; Pottage MJ; Mudie ST; Pearson GR; Wilkinson BL; Tabor RF
J Colloid Interface Sci; 2019 Mar; 540():410-419. PubMed ID: 30665167
[TBL] [Abstract][Full Text] [Related]
31. The influence of mannose-based esters on the mesophase behaviour of lyotropic liquid crystalline nanosystems as drug delivery vectors.
Tiboni M; Astolfi P; Verboni M; Benedetti S; Giorgini E; Notarstefano V; Vita F; Ranieri S; Duranti A; Lucarini S; Casettari L; Pisani M
Colloids Surf B Biointerfaces; 2023 Dec; 232():113596. PubMed ID: 37918304
[TBL] [Abstract][Full Text] [Related]
32. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions.
Bitan-Cherbakovsky L; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Oct; 115(42):11984-92. PubMed ID: 21902258
[TBL] [Abstract][Full Text] [Related]
33. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
34. The Influence of Hydrophobic Blocks of PEO-Containing Copolymers on Glyceryl Monooleate Lyotropic Liquid Crystalline Nanoparticles for Drug Delivery.
Forys A; Chountoulesi M; Mendrek B; Konieczny T; Sentoukas T; Godzierz M; Kordyka A; Demetzos C; Pispas S; Trzebicka B
Polymers (Basel); 2021 Aug; 13(16):. PubMed ID: 34451146
[TBL] [Abstract][Full Text] [Related]
35. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
Cohen-Avrahami M; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
[TBL] [Abstract][Full Text] [Related]
36. Long-living intermediates during a lamellar to a diamond-cubic lipid phase transition: a small-angle X-ray scattering investigation.
Angelov B; Angelova A; Vainio U; Garamus VM; Lesieur S; Willumeit R; Couvreur P
Langmuir; 2009 Apr; 25(6):3734-42. PubMed ID: 19708151
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
[TBL] [Abstract][Full Text] [Related]
38. Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect.
Boge L; Bysell H; Ringstad L; Wennman D; Umerska A; Cassisa V; Eriksson J; Joly-Guillou ML; Edwards K; Andersson M
Langmuir; 2016 May; 32(17):4217-28. PubMed ID: 27033359
[TBL] [Abstract][Full Text] [Related]
39. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior.
Caboi F; Amico GS; Pitzalis P; Monduzzi M; Nylander T; Larsson K
Chem Phys Lipids; 2001 Jan; 109(1):47-62. PubMed ID: 11163344
[TBL] [Abstract][Full Text] [Related]
40. Lyotropic liquid crystalline phases with a series of N-alkyl-N-methylpiperidinium bromides and water.
Zhao Y; Yue X; Wang X; Chen X
J Colloid Interface Sci; 2013 Jan; 389(1):199-205. PubMed ID: 23062960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
